TrialRevista da Sociedade Brasileira de Medicina Tropical2023

Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors).

Lívia Pimenta Bonifácio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.